Organovo Holdings, Inc. Company

At Organovo, we design and create functional human tissues using our proprietary three-dimensional bioprinting technology. Our goal is to build living human tissues that are proven to function like native tissues. Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.

Funding Status: IPO
Industry: Regenerative Medicine
Number Of Exists: N/A
Technology: Regenerative Medicine - other
Founded Date: 2007
Investor Type: N/A
Headquarters: San Diego
Employee Number: Undisclosed
Investment Stage: N/A